Different Expression of MicroRNA-146a in Peripheral Blood CD4+ T Cells and Lesions of Oral Lichen Planus
- 322 Downloads
Oral lichen planus (OLP) is a common T cell-mediated chronic inflammatory disease of unknown etiology. Recent increasing evidence indicates that microRNA-146a (miR-146a) plays a vital role in inflammatory diseases and T cell regulation. This study aimed to investigate the expression of miRNA-146a in peripheral blood CD4+ T cells and local OLP lesions and to evaluate its relationship with clinical forms of OLP. Sixteen patients with OLP were divided into two groups: erosive OLP and nonerosive OLP. The expression of miR-146a was examined by quantitative real-time polymerase chain reaction. The expression of miR-146a in peripheral blood CD4+ T cells showed no significant difference between OLP group and control group (P > 0.05), and among erosive OLP, nonerosive OLP, and control groups (P > 0.05 for all). The expression in local lesions of the OLP group was significantly higher than that of the control group (P = 0.003), and it was significantly higher in the erosive OLP group than in the non-erosive OLP (P = 0.010) and control groups (P = 0.007). However, miR-146a expression in the nonerosive OLP group did not significantly differ from that in the control group (P > 0.05). These data indicate that miR-146a might be more involved in the local immune disorder of OLP. MiR-146a might be utilized as a candidate biomarker to estimate the severity of OLP.
KEY WORDSoral lichen planus microRNA-146a CD4+ T cells lesion
This work was supported by grants from the National Natural Science Foundation of China (Nos. 81170972 and 81371147) to Gang Zhou.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no competing interests.
- 3.Al-Hashimi, I., M. Schifter, P.B. Lockhart, D. Wray, M. Brennan, C.A. Migliorati, T. Axell, A.J. Bruce, W. Carpenter, E. Eisenberg, J.B. Epstein, P. Holmstrup, M. Jontell, F. Lozada-Nur, R. Nair, B. Silverman, K. Thongprasom, M. Thornhill, S. Warnakulasuriya, and I. van der Waal. 2007. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 103(S25): e21–12.Google Scholar
- 10.Taganov, K.D., Fau Boldin Mp, K.-J. Chang, Fau Chang Kj, D. Baltimore, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 103(33): 12481–12486.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Mohnle, P., S.V. Schutz, V. van der Heide, M. Hubner, B. Luchting, J. Sedlbauer, E. Limbeck, L.C. Hinske, J. Briegel, and S. Kreth. 2015. MicroRNA-146a controls Th1-cell differentiation of human CD4+ T lymphocytes by targeting PRKCepsilon. European Journal of Immunology 45(1): 260–272.CrossRefPubMedGoogle Scholar
- 14.Perry, M.M., S.A. Moschos, A.E. Williams, N.J. Shepherd, H.M. Larner-Svensson, and M.A. Lindsay. 2008. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. Journal of Immunology 180(8): 5689–5698.CrossRefGoogle Scholar
- 15.Curtale, G., Citarella F. Fau, C. Carissimi, Carissimi C. Fau, M. Goldoni, Goldoni M. Fau, N. Carucci, Carucci N. Fau, V. Fulci, Fulci V. Fau, D. Franceschini, Franceschini D. Fau, F. Meloni, Meloni F. Fau, V. Barnaba, Barnaba V. Fau, G. Macino, and G. Macino. 2010. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115(2): 265–273.CrossRefPubMedGoogle Scholar
- 22.Zhou, G., K. Xia, G.F. Du, X.M. Chen, X.Y. Xu, R. Lu, and H.M. Zhou. 2009. Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form. Journal of Oral Pathology & Medicine 38(7): 559–564.CrossRefGoogle Scholar
- 24.Boldin, M.P., K.D. Taganov, D.S. Rao, L. Yang, J.L. Zhao, M. Kalwani, Y. Garcia-Flores, M. Luong, A. Devrekanli, J. Xu, et al. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. The Journal of Experimental Medicine 208(6): 1189–1201.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Kutty, R.K., C.N. Nagineni, W. Samuel, C. Vijayasarathy, C. Jaworski, T. Duncan, J.E. Cameron, E.K. Flemington, J.J. Hooks, and T.M. Redmond. 2013. Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1beta, tumor necrosis factor-alpha, and interferon-gamma. Molecular Vision 19: 737–750.PubMedPubMedCentralGoogle Scholar
- 30.Tao, X., Y. Huang, R. Li, R. Qing, L. Ma, N.L. Rhodus, and B. Cheng. 2007. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 103(5): 661–669.CrossRefPubMedGoogle Scholar
- 36.Garcia, A.I., M. Buisson, P. Bertrand, R. Rimokh, E. Rouleau, B.S. Lopez, R. Lidereau, I. Mikaelian, and S. Mazoyer. 2011. Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Molecular Medicine 3(5): 279–290.CrossRefPubMedPubMedCentralGoogle Scholar